HopeStage
Back to all studies
CompletedNCT02649231

Ketamine and Therapy to Reduce Alcohol Relapse

About this titleRead the official source — NCT02649231
Medication studyAges 18–60United KingdomAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations
Exeter and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 2016
Recruitment status
Completed
Enrollment listed in the registry
96
Sponsor
University College, London
Sponsor type
University
Study type
Drug
Intervention type
Behavioural, Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United Kingdom
Age range
From 18 Years to 60 Years
Official registry ID
NCT02649231
Official title
Show the full official title

A Phase II, Randomised, Double-blind, Placebo- Controlled, Multi-site, Parallel Group Clinical Trial to Examine Ketamine as a Pharmacological Treatment for Alcohol Dependence in an Alcohol Dependent Population

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Exeter · London

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University College, London, a university.

Did this study involve medication?

Yes. The study involved medication, including ketamine and Placebo.

Who was this study for?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies